Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Rosalind Franklin University and Aptinyx collaborate on therapeutics for brain and CNS disorders

Sep. 23, 2021

Preclinical evaluation of novel mAChR subtype-selective M1 PAMs

Sep. 23, 2021

MIPS-521 exerts analgesic efficacy through stabilization of GPCR-G protein complex dynamics

Sep. 23, 2021

Synthetic queuine STL-101 shows neuroprotective potential

Sep. 22, 2021

CMTA and Addex collaborate to investigate GABA-B PAMs for CMT1A

Sep. 22, 2021

Clearmind and Hebrew University partner on novel psychedelics

Sep. 22, 2021

Virpax acquires rights to Nanomerics' technology to deliver intranasal cannabidiol product

Sep. 21, 2021

Mindset reports preclinical data on next-generation psychedelic medicine MSP-4018

Sep. 21, 2021

Linagliptin ameliorates neurodegeneration in rat model of AD

Sep. 21, 2021

Exosome-mediated transcellular delivery of SIRT2 modulates ATP homeostasis within axons

Sep. 21, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 19, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Authorities work to quickly sequence Ebola species in latest outbreak
BioWorld
If the recent hantavirus outbreak wasn’t enough to keep public health officials busy, a new Ebola virus disease outbreak has been confirmed by authorities in the...
Camp4 studies CMP-002 in SYNGAP1 haploinsufficient mouse model
BioWorld Science
Camp4 Therapeutics Corp. has highlighted new preclinical data for CMP-002, the company’s lead investigational antisense oligonucleotide (ASO) therapeutic...